Cargando…

Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein

The pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), is the aggregation of α-synuclein (α-Syn) protein. Even so, tau protein pathology is abundantly found in these diseases. Both α-Syn and tau can exist as polymorphic aggregates, a phenomenon that has been widely studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Urmi, Puangmalai, Nicha, Bhatt, Nemil, Garcia, Stephanie, Zhao, Yingxin, Kayed, Rakez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253398/
https://www.ncbi.nlm.nih.gov/pubmed/32350746
http://dx.doi.org/10.1007/s12035-020-01913-6
_version_ 1783539329241448448
author Sengupta, Urmi
Puangmalai, Nicha
Bhatt, Nemil
Garcia, Stephanie
Zhao, Yingxin
Kayed, Rakez
author_facet Sengupta, Urmi
Puangmalai, Nicha
Bhatt, Nemil
Garcia, Stephanie
Zhao, Yingxin
Kayed, Rakez
author_sort Sengupta, Urmi
collection PubMed
description The pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), is the aggregation of α-synuclein (α-Syn) protein. Even so, tau protein pathology is abundantly found in these diseases. Both α-Syn and tau can exist as polymorphic aggregates, a phenomenon that has been widely studied, mostly in their fibrillar assemblies. We have previously discovered that in addition to α-Syn oligomers, oligomeric tau is also present in the brain tissues of patients with PD and dementia with Lewy bodies (DLB). However, the effect of interaction between polymorphic α-Syn oligomers and tau has not been scrupulously studied. Here, we have explored the structural and functional diversity of distinct α-Syn oligomers, prepared by modifying the protein with dopamine (DA) and docosahexaenoic acid (DHA). The two α-Syn oligomers differed in aggregate size, conformation, sensitivity to proteinase K digestion, tryptic digestion, and toxicity, suggesting them as distinct α-Syn oligomeric strains. We examined their internalization mechanisms in primary neurons and seeding propensity in inducing α-Syn aggregation. Using a combined approach of molecular and cellular techniques, we observed that the tau aggregates cross-seeded with the individual α-Syn oligomeric strains differed in their biochemical and biological properties, suggesting two distinct tau strains. The tau aggregate cross-seeded with the DA-modified α-Syn oligomeric strain possessed a potent intracellular tau seeding propensity. This study provides a comprehensive analysis of unique strain-specific interaction between oligomeric α-Syn and tau. Furthermore, this study allows us to speculate that distinct α-Syn-tau interactions inducing tau aggregation might be an underlying mechanism of neurodegeneration in PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12035-020-01913-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7253398
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72533982020-06-05 Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein Sengupta, Urmi Puangmalai, Nicha Bhatt, Nemil Garcia, Stephanie Zhao, Yingxin Kayed, Rakez Mol Neurobiol Article The pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), is the aggregation of α-synuclein (α-Syn) protein. Even so, tau protein pathology is abundantly found in these diseases. Both α-Syn and tau can exist as polymorphic aggregates, a phenomenon that has been widely studied, mostly in their fibrillar assemblies. We have previously discovered that in addition to α-Syn oligomers, oligomeric tau is also present in the brain tissues of patients with PD and dementia with Lewy bodies (DLB). However, the effect of interaction between polymorphic α-Syn oligomers and tau has not been scrupulously studied. Here, we have explored the structural and functional diversity of distinct α-Syn oligomers, prepared by modifying the protein with dopamine (DA) and docosahexaenoic acid (DHA). The two α-Syn oligomers differed in aggregate size, conformation, sensitivity to proteinase K digestion, tryptic digestion, and toxicity, suggesting them as distinct α-Syn oligomeric strains. We examined their internalization mechanisms in primary neurons and seeding propensity in inducing α-Syn aggregation. Using a combined approach of molecular and cellular techniques, we observed that the tau aggregates cross-seeded with the individual α-Syn oligomeric strains differed in their biochemical and biological properties, suggesting two distinct tau strains. The tau aggregate cross-seeded with the DA-modified α-Syn oligomeric strain possessed a potent intracellular tau seeding propensity. This study provides a comprehensive analysis of unique strain-specific interaction between oligomeric α-Syn and tau. Furthermore, this study allows us to speculate that distinct α-Syn-tau interactions inducing tau aggregation might be an underlying mechanism of neurodegeneration in PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12035-020-01913-6) contains supplementary material, which is available to authorized users. Springer US 2020-04-29 2020 /pmc/articles/PMC7253398/ /pubmed/32350746 http://dx.doi.org/10.1007/s12035-020-01913-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sengupta, Urmi
Puangmalai, Nicha
Bhatt, Nemil
Garcia, Stephanie
Zhao, Yingxin
Kayed, Rakez
Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title_full Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title_fullStr Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title_full_unstemmed Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title_short Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
title_sort polymorphic α-synuclein strains modified by dopamine and docosahexaenoic acid interact differentially with tau protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253398/
https://www.ncbi.nlm.nih.gov/pubmed/32350746
http://dx.doi.org/10.1007/s12035-020-01913-6
work_keys_str_mv AT senguptaurmi polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein
AT puangmalainicha polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein
AT bhattnemil polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein
AT garciastephanie polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein
AT zhaoyingxin polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein
AT kayedrakez polymorphicasynucleinstrainsmodifiedbydopamineanddocosahexaenoicacidinteractdifferentiallywithtauprotein